Monovalent influenza vaccine A (H5N8), inactivated, fragmented and adjuvanted

Influenza A(H5N8) vaccine, inactivated, fragmented, adjuvanted · Butantan Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Monovalent influenza vaccine A (H5N8), inactivated, fragmented and adjuvanted, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults [Phase 1, Phase 2]

See pricing